
Ronald C Petersen MD
Neurodegenerative, Dementia & Geriatrics
Neurologist and Cora Kanow P rofessor of Alzheimer’s Disease Research at Mayo Clinic Director of Mayo Alzheimer’s Disease Research Center Chair of the Advisory Council on Research, Care and Services for the National Alzheimer’s Project Act, and is on the World Dementia Council
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Fax+1 507-538-6012
Dr. Petersen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1984 - 1986
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1981 - 1984
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1980 - 1981
- Mayo Clinic College of MedicineClass of 1980
Certifications & Licensure
- AZ State Medical License 1991 - 2026
- MN State Medical License 1981 - 2026
- FL State Medical License 1991 - 2024
- WI State Medical License 1981 - 2007
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
Clinical Trials
- ADNI: Alzheimer's Disease Neuroimaging Initiative Start of enrollment: 2005 Jul 01
- Alzheimer's Disease Neuroimaging Initiative Grand Opportunity Start of enrollment: 2010 Apr 01
- Alzheimer's Disease Neuroimaging Initiative 2 Start of enrollment: 2011 Feb 14
- Join now to see all
Publications & Presentations
PubMed
- White matter hyperintensities in dementia with lewy bodies and posterior cortical atrophy.Neha Singh-Reilly, Nha Trang Thu Pham, Jonathan Graff-Radford, Mary M Machulda, Anthony J Spychalla
Neurobiology of Aging. 2025-06-01 - Patterns of Factors in the National Institute on Aging Health Disparities Research Framework Domains and Mild Cognitive Impairment Risk.Maria Vassilaki, Jeremiah A Aakre, Timothy G Lesnick, Walter K Kremers, Jonathan Graff-Radford
AJPM Focus. 2025-06-01 - Relation of Alzheimer's disease-related TDP-43 proteinopathy to metrics from diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NOD...Anna Lavrova, Nha Trang Thu Pham, Robert I Reid, Bradley F Boeve, David S Knopman
Neurobiology of Aging. 2025-06-01
Journal Articles
- Association of Initial Β-amyloid Levels with Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive ImpairmentDavid S Knopman, Bradley F Boeve, Ronald C Petersen, Clifford R Jack, JAMA Neurology
- Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without DementiaMary M Machulda, Ronald C Petersen, David S Knopman, Yonas E Geda, Val J Lowe, Journal of the American Geriatrics Society
- Association of Apolipoprotein E ε4 with Transactive Response DNA-Binding Protein 43Bradley F Boeve, Dennis W Dickson, David S Knopman, Joseph E Parisi, Ronald C Petersen, Keith A Josephs, JAMA
- Join now to see all
Other
- Mild cognitive impairment: Epidemiology, pathology, and clinical assessmentPetersen RC, McDade EM
http://www.uptodate.com/contents/mild-cognitive-impairment-epidemiology-pathology-and-clinical-asses
UpToDate, Wolters Kluwer Health - 2011-10-05 - Mild cognitive impairment: Prognosis and treatmentPetersen RC, McDade EM
http://www.uptodate.com/contents/mild-cognitive-impairment-prognosis-and-treatment
UpToDate, Wolters Kluwer Health - 2013-02-06
Press Mentions
- Could Popular Weight-Loss Drugs Help Treat Addiction and Dementia?March 13th, 2025
- In Case You Missed It: This Week’s Top 5 Stories on Social MediaNovember 15th, 2024
- How Cannabis Is Changing Dementia Care for Patients and FamiliesNovember 14th, 2024
- Join now to see all
Grant Support
- Mayo Alzheimer's Disease Research CenterMAYO CLINIC ROCHESTER2019–2029
- Mayo Alzheimer's Disease Research CenterMAYO CLINIC ROCHESTER2019–2029
- Mayo Alzheimer's Disease Research CenterMAYO CLINIC ROCHESTER2019–2029
- Mayo Alzheimer's Disease Research CenterMAYO CLINIC ROCHESTER2019–2029
- Mayo Alzheimer's Disease Research CenterMAYO CLINIC ROCHESTER2019–2029
- Alzheimer's Clinical Trials Consortium (ACTC)UNIVERSITY OF SOUTHERN CALIFORNIA2017–2028
- Alzheimer's Clinical Trials Consortium (ACTC)UNIVERSITY OF SOUTHERN CALIFORNIA2017–2028
- Alzheimer's Clinical Trials Consortium (ACTC)UNIVERSITY OF SOUTHERN CALIFORNIA2017–2028
- MarkVCID Validation in the General CommunityMAYO CLINIC ROCHESTER2021–2026
- MarkVCID Validation in the General CommunityMAYO CLINIC ROCHESTER2021–2026
- MarkVCID Validation in the General CommunityMAYO CLINIC ROCHESTER2021–2026
- Alzheimers Disease Patient Registry (Administrative Supplement)MAYO CLINIC ROCHESTER1986–2025
- Alzheimers Disease Patient Registry (Administrative Supplement)MAYO CLINIC ROCHESTER1986–2025
- Alzheimers Disease Patient Registry (Administrative Supplement)MAYO CLINIC ROCHESTER1986–2025
- Clinical CoreNational Institute On Aging2009–2012
- Mayo Alzheimer'S Disease Research CenterNational Institute On Aging2004–2012
- Administrative CoreNational Institute On Aging2004–2012
- Mayo Alzheimers Disease Research CenterNational Institute On Aging1999–2003
- Mayo Alzheimer'S Disease Research Center-SupplementNational Institute On Aging2001
- Mayo Alzheimer'S Disease Research CenterNational Institute On Aging2000
- Alzheimers Disease Research CenterNational Institute On Aging1999
- Alzheimers Disease CenterNational Institute On Aging1995–1998
- Alzheimers Disease Center Core GrantNational Institute On Aging1994
- Alzheimer'S Disease Center Core GrantNational Institute On Aging1993
- Alzheimer'S Disease And Normal Aging:Mr Volume MeasuresNational Institute Of Neurological Disorders And Stroke1991–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: